Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis

Overview

The primary objective of the study is to determine sleep disturbance and its types among patients with gastrointestinal cancers during the perioperative period (preoperative and in-hospital stay following surgery) by using Richard Campbell sleep questionnaire (RCSQ). The primary objective of this study is to determine the SD during preoperative and post-operative periods evaluated by Richard Campbell Sleep questionnaire. Patients will be asked every 24 hours while at the hospital (before and after surgery) to fill out this questionnaire. The mean RCSQ score at each time point (i.e., before and after surgery) will be calculated for each patient. The overall mean (across all patients) will be calculated and reported along a 95% CI.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Screening
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 30, 2022

Detailed Description

Primary: • Determine sleep disturbance and its types among patients with gastrointestinal cancers during the perioperative period (preoperative and in-hospital stay following surgery) by using Richard Campbell sleep questionnaire(RCSQ). Secondary: – Determine sleep disturbance and its types at 30 day post-discharge follow-up visit by RCSQ. – Determine the correlation between objective sleep variables assessed using Actigraphy and Fitbit and patient-reported SD on Richard Campbell Sleep questionnaire. – Determine the association of severity and impact of SD among Quality of recovery (QoR-15), Pittsburgh sleep quality index, MDASI-GI and Richard Campbell Sleep questionnaire, and Insomnia Severity Index (ISI). Exploratory: • Determine the association between the preoperative inflammatory burden, sleep health {insomnia (using Insomnia Severity Index (ISI)),sleep architecture(sleep-wake cycles usingActigraphy)}, and perioperative inflammatory responses on postoperative SD

Interventions

  • Other: Sleeping Disturbances
    • most common complaints of patients after surgery and may affect the ability to carry out daily activities, quality of life, and post-surgery recovery.

Arms, Groups and Cohorts

  • Other: Sleep Disturbances
    • Difficulty Sleeping

Clinical Trial Outcome Measures

Primary Measures

  • Correlating the sleep disturbance and its types among patients with gastrointestinal cancers.
    • Time Frame: through study completion, an average of 1 year
    • This questionnaire will be used to assess during the stay by using (preoperative and in-hospital stay following surgery) by using Richard Campbell sleep questionnaire(RCSQ). scale of 1 to 10 (with 1 being “poor” and 10 being “excellent

Participating in This Clinical Trial

Inclusion Criteria

1. Adult GI Cancer patients admitted for elective gastrointestinal surgery. 2. Patients with an expected hospitalstay of at least 72 hours. 3. Able to be able to read and speak English. 4. Must have access to internet or use of mobile device for FitBit. Exclusion Criteria:

1. <18 years of age. 2. Night shift workers. Obtained from job history, any patient >/= 2 days per week, within the last six months prior consenting, are not eligible.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • M.D. Anderson Cancer Center
  • Collaborator
    • American Cancer Society, Inc.
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Sriram Yennu, Principal Investigator, M.D. Anderson Cancer Center
  • Overall Contact(s)
    • Sriram Yennu, 713-792-3938, syennu@mdanderson.org

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.